30P Nowa fizyczna metoda wczesnego diagnozowania i monitorowania leczenia chorych z rozpoznaniem nowotworu

Pole magnetyczne o indukcji B > 10 tesli znajduje zastosowanie w analizie indukowanej dwójłomności kołowej surowicy krwi. Analiza oddziaływania silnego pola magnetycznego i elektromagnetycznego pola wiązki świetlnej z surowicą krwi wykazała, że w silnym polu magnetycznym ujawnia się wyraźnie ilościowa różnica magneto-optycznych efektów obserwowanych dla surowic dawców krwi chorych z nowotworami. Dokonano analizy 110 surowic krwi. Pomiary wykonano w silnym impulsowym (B ≅ 30 tesli). Próbki surowicy 23 dawców krwi zostały poddane badaniom mającym na celu określenie naturalnej aktywności optycznej. Surowice te stanowiły punkt odniesienia do analiz surowic chorych onkologicznych. Analizowano surowice chorych z rozpoznaniem raka prostaty, jelita grubego, raka jajnika, w którym w trakcie leczenia oznacza się poziom markerów nowotworowych. Druga grupa chorych to pacjenci z mierzalnymi guzami gruczołu piersiowego, mięsaka, czerniaka, szpiczaka. Dokonano pomiarów magneto-optycznych współczynników a, b, c oraz naturalnej aktywności optycznej α0 surowic.Wykazano wyraźną współzależność między stanem chorego, a wartością współczynnika b oraz jego korelacją ze wzrostem poziomu markerów nowotworowych lub wielkością ognisk przerzutowych. Prowadzone po raz pierwszy badania magnatyczno-optycznej dwójłomności kołowej surowicy są szybką metodą analityczną. Mogą w przyszłości mieć zastosowanie w diagnostyce i monitorowaniu leczenia nowotworów

Life quality of the advanced ear cancer patient treated with combined radiotherapy and chemotherapy

A 43 years old woman was admitted to our hospital in July 1996 with large, ulcerated infiltration of the external, middle and internal ear. A cortical bone of the temporal pyramid was involved and destroyed from the inside of the skull.Cancer of the ear was preceded by a discoid lupus erythematodes lesion. Histopatologhical examination confirmed the diagnosis – keratinized squamous cell cancer.The patient was treated with radiation therapy (3 Gy per day, Co-60, isocentre technique, total dose of 54 Gy was delivered with two-week rest) and chemotherapy (MTX and BLEO once a week) concurrently.The follow up in January 1997 with CT examination revealed a small lesion in the external auditory meatus. The patient was proposed a wide surgical excision of the recurrence. She denied surgery and was irradiated using small fields, 2 Gy per fraction to the total dose of 14 Gy.Presently, the patient is living without pain. There is small pus discharge from the external auditory meatus. The lupus lesions in the irradiated volume are healed.In conclusion, the palliative radiotherapy was a reasonable alternative to the extensive surgical excision

70. Meningiomas treated in Greatpoland Cancer Center between 1990–1997

IntroductionWe analyzed correlation between age of patient with anaplastic meningiomas, extension of tumor excision, histopatological recognition and time to recurrence and survival.Material and methodsBetween 1990–1997 7 patients with anaplastic meningioma, 3 patients with haemangiopericytoma, 2 patients with sarcoma meningeum (6 women and 6 men) have been irradiated. 7 patients underwent radical excision of the tumor, 5 patients non radical. The patients were irradiated from limited fields to total dose 56–60 Gy/T mostly by energy Co-60 (9 patients) and photons 9 MV (3 patients).ResultsThere are 6 patients with anaplasticum meningioma still alive. 3 patients living 96–108 months, 3 other 30–39 months. Recurrence was confirmed in two male participants who underwent radical surgery in 12 and 29 month from the start of treatment. The first patient died after 16 months with recurrence of the disease. One patient (39 years old) with heamangiopericytoma lives 40 months after radical surgery without evidence of recurrence. Two patients died – one 11 months after radical surgery (41 years old) and the other one (42 years old) 21 months after non radical surgery. Both patients (24 and 59 years old) with sarcoma died (one after 8 months, and the other one after 21 months).ConclusionsPatient with anaplastic meningiomas have long survival. The extension of tumor excision didn’t influence on survival

71. The results of postoperative radiotherapy in 63 patients with low-grade gliomas treated in Greatpoland Cancer Center

IntroductionLow-grade glicomas represents 15% of all primary brain tumors.Material and MethodBetween 1990–97 63 patient with low-grade gliomas were treated in Greatpoland Cancer Center (39 males, 24 females; age between 20–60 year). 15 patients had andegrone complete surgical excision, 48 partial or subtotal excision of tumor. The frontal lobe was affected in 33 patients, the temporal lobe in 14 patients. Patients received conventional irradiaton of 60 Gy.Results*Five patients with histologically verified pilocytic astrocytomas(I) were treated after partial excision, median of age 29.2 year median survival 58 months (27–108). Only one patient died 27 months after radiotherapy. *Thirteen patients with fibrylar astrocytomas(II)-11 post subtotal excision-median age 37.7 year median survival 32.5 months. Recurrent tumor in two patients. Five patients are alive. *Ten patients with protoplasmatic astrocytoma(II)-7 post subtotal excision median of age 43.5 year median survival 30.8 months. Four patients alive. *Seven patients with gemistocytic astrocytomas(II) (6 post subtotal excision)-median age 36 year, median survival 32 months. Only one patient alive. *Eleven patients with oligoastrocytomas(II)-11 post subtotal excision, median age 38.6 year, median survival 43.9 months. Two patients with recrrent tumor. Alive 8 patients. *Seventeen patients with oligodendrogliomas (11 post subtotal excision) median age 39 years, median survival 39 months. One patien with recrrent tumor. Alive 8 patients.Conclusions*30 patients are alive(48%); *histopathologic diagnosis pilocytic astrocytomas asociated with age 10 years younger then either low-grade gliomas and long-term survivors; *poor prognistic factor in gemistocytic astrocytomas-only one patient alive; *five patients with recurrent tumor among 17 to 49 months after radiotheraphy

Phase separation in a lattice model of a superconductor with pair hopping

We have studied the extended Hubbard model with pair hopping in the atomic limit for arbitrary electron density and chemical potential. The Hamiltonian considered consists of (i) the effective on-site interaction U and (ii) the intersite charge exchange interactions I, determining the hopping of electron pairs between nearest-neighbour sites. The model can be treated as a simple effective model of a superconductor with very short coherence length in which electrons are localized and only electron pairs have possibility of transferring. The phase diagrams and thermodynamic properties of this model have been determined within the variational approach, which treats the on-site interaction term exactly and the intersite interactions within the mean-field approximation. We have also obtained rigorous results for a linear chain (d=1) in the ground state. Moreover, at T=0 some results derived within the random phase approximation (and the spin-wave approximation) for d=2 and d=3 lattices and within the low density expansions for d=3 lattices are presented. Our investigation of the general case (as a function of the electron concentration and as a function of the chemical potential) shows that, depending on the values of interaction parameters, the system can exhibit not only the homogeneous phases: superconducting (SS) and nonordered (NO), but also the phase separated states (PS: SS-NO). The system considered exhibits interesting multicritical behaviour including tricritical points.Comment: 15 pages, 9 figures; pdf-ReVTeX, final version, corrected typos; submitted to Journal of Physics: Condensed Matte

Thermal properties of large main-belt asteroids observed by Herschel PACS

Non-resolved thermal infrared observations enable studies of thermal and physical properties of asteroid surfaces provided the shape and rotational properties of the target are well determined via thermo-physical models. We used calibration-programme Herschel PACS data (70, 100, 160 $\mu$m) and state-of-the-art shape models derived from adaptive-optics observations and/or optical light curves to constrain for the first time the thermal inertia of twelve large main-belt asteroids. We also modelled previously well-characterised targets such as (1) Ceres or (4) Vesta as they constitute important benchmarks. Using the scale as a free parameter, most targets required a re-scaling $\sim$5\% consistent with what would be expected given the absolute calibration error bars. This constitutes a good cross-validation of the scaled shape models, although some targets required larger re-scaling to reproduce the IR data. We obtained low thermal inertias typical of large main belt asteroids studied before, which continues to give support to the notion that these surfaces are covered by fine-grained insulating regolith. Although the wavelengths at which PACS observed are longwards of the emission peak for main-belt asteroids, they proved to be extremely valuable to constrain size and thermal inertia and not too sensitive to surface roughness. Finally, we also propose a graphical approach to help examine how different values of the exponent used for scaling the thermal inertia as a function of heliocentric distance (i.e. temperature) affect our interpretation of the results.Comment: Accepted for publication in Astronomy & Astrophysics (preprint version

70 Wyniki leczenia chorych na raka sutka w stadium rozsiewu w materiale Wielkopolskiego Centrum Onkologii

WstępLeczenie chorych na raka sutka w stadium rozsiewu (M1) ma charakter paliatywny. Metody leczenia obejmują radioterapię, chemioterapię, hormonoterapię w monoterapii lub jako leczenie skojarzone. Wyniki leczenia są najczęściej złe. Przedstawiamy wyniki leczenia chorych na raka sutka w stadium rozsiewu leczonych w Wielkopolskim Centrum Onkologii.Materiał i metody95 chorych na raka sutka w stadium M1 leczono w latach 1983–1987 w Wielkopolskim Centrum Onkologii. Wiek chorych wahał się od 29 do 74 lat, średnio 51,5 lat. W grupie 65 chorych pierwszym umiejscowieniem przerzutów był kościec, w dalszej kolejności płuca i wątroba. Większość chorych leczona była cytostatykami lub hormonami, u części zastosowano paliatywną radioterapię. Wyniki leczenia opracowano na podstawie historii chorób i przeprowadzonej katamnezie. Grupę badaną poddano 5-letniej obserwacji.Wyniki8 chorych (8,4%) przeżyło 5 lat od momentu rozpoczęcia leczenia zmian przerzutowych. Średni okres przeżycia w całej grupie wyniósł 13,5 miesiąca.WnioskiPomimo złego rokowania leczeniem systemowym udaje się przedłużyć życie części chorych na raka sutka, u których wystąpiły przerzuty odległe

79. The effectivness of pain treatment with Strontium 89 in patient with osseous metastases

Aimof this study was to assessment of 89 Sr therapy as pain treatment modality in the group of patients with multiple bone metastases.Material and methodsFrom January 2000 to October 2000 in our center were treated 41 patients; 17 – prostate cancer and 24 – breast cancer patients. All patients had applied only one dose of 150 MBq of 89 Sr. Before and follow-up each patient has been evaluated; performance status according to the Karnofsky Scale and paro intensity according the VAS scale. We did not observe any clinical important haematological side effects. The ionisation dosemetric monitoring of the sources and the radioactive refuse were recorded. The radioactive refuse was storage in special container when the activity decreased to the background.ResultsWe noted relief of paro as follow:-“complete” 18 of 41 patients (8-prostate cancer, 10 – breast cancer),-“partial” 12 of 41 patients (3- prostate cancer, 9- breast cancer),-“no effect” 11 of 41 patients (6-prostate cancer, 5- breast cancer).ConclusionsWe suggest that therapy of painful multiple bone metastases with application of 89 Sr is effective nd safe